Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial (Q33806121)

29 July 2017

title

Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial (English)

1 reference

29 July 2017

main subject

pulmonary hypertension

1 reference

Hans-Jürgen Seyfarth

1

1 reference

29 July 2017

Stefan Hammerschmidt

2

1 reference

29 July 2017

Michael Halank

3

1 reference

29 July 2017

Petra Neuhaus

4

1 reference

29 July 2017

Hubert R Wirtz

5

1 reference

29 July 2017

publication date

1 September 2013

1 reference

29 July 2017

published in

Pulmonary circulation

1 reference

29 July 2017

volume

3

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

632-638

1 reference

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Systemic sclerosis-associated pulmonary arterial hypertension

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Everolimus: a proliferation signal inhibitor targeting primary causes of allograft dysfunction.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070806

Chronic Thromboembolic Pulmonary Hypertension

4 July 2018

1 reference

Standard PAH therapy improves long term survival in CTEPH patients.

21 January 2018

1 reference

Imatinib for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients

21 January 2018

1 reference

Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis

21 January 2018

1 reference

12 December 2020

Prognoses of primary pulmonary hypertension and chronic majorvessel thromboembolic pulmonary hypertension determined from cumulative survival curves

1 reference

12 December 2020

Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats

1 reference

12 December 2020

Portopulmonary Hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1086/674311

1 reference

29 July 2017

1 reference

29 July 2017

1 reference